Progressive Care Inc (RXMD)

[Jimmy Quick]

Here is what I have come up with so far?

Has Benchmark officially raised the $10 million in capital?

What is your target share price before enacting a reverse split?

What is range of new reverse split proposal for proxy vote?

Any merger news?

How do you plan to expand without dilution?

When do you plan on pulling in profits?

When do we anticipate NASDAQ uplist?

How much of the Chicago Ventures/Illiad Debt do you plan to pay off, principle balance at 6/30/21 was $1,759,700 and with Accrued Interest of $712,411? The 12.5% of Net Proceeds only represents 50% of outstanding debt. What is being used to cover the rest before March 2022?

Have there been any new revenues attributed to ClearMetrX?

Have there been any recent 340B Institution Additions/Deletions?

How is “myVax” intended to create revenues?

What will our business look like in the next 3 years going forward as a result of management's plan to grow and/or change our services.

Will you need to revise the S-1 due to Oleg Firer’s employment status change with Net Element and do they need to add Q3 financials in the revised S-1.

What’s this about conversion of Preferred Voting Shares to a Trust? These were designed just for voting control purposes, why would there be a conversion to common stock, hence any need for a Trust other than to hold these Preferred Shares in event of delist?

From Financial Statements
Certificate of Designation of Rights, Preferences and Privileges of Series A Super-Voting Preferred Stock of the Company.
On July 11, 2014, the board of directors approved the issuance of 51 shares of the Company’s Series A Preferred Stock to a certain
employee of the Company, which is equal to 50.99% of the total voting power of all issued and outstanding voting capital of the Company
in satisfaction of $20,000 in past due debt.

From S1 Prospectus Issued 10-12-21
Recent Developments

Exchange of Series A Preferred Stock

We have negotiated an exchange agreement with the Yelena Braslavskaya 2020 Gift Trust, the holder of all of our outstanding shares of Series A Preferred Stock, to exchange all of the shares of Series A Preferred Stock into shares of our common stock. We expect to enter into an exchange agreement and complete the exchange simultaneously with the closing of this offering.